Differences in aggregation properties of three site-specific mutants of recombinant human stefin B

Protein Science

Volumn 13, Issue 1, 2004, Pages 63-70

  Kenig, Manca ^a   Berbić, Selma ^b   Kriještorac, Aida ^b   Kroon Žitko, Louise ^a   Tušek, Magda ^c   Pompe Novak, Maruša ^c   Žerovnik, Eva ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF TUZLA   (Bosnia and Herzegovina)

^c NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

Author keywords

Amyloid fibrils; Circular dichroism (CD); Conformational disease; Cystatins; Domain swapped dimer; Proline mutants; Protein folding

Indexed keywords

AMYLOID; MONOMER; RECOMBINANT PROTEIN; STEFIN B;

ARTICLE; CIRCULAR DICHROISM; ELUTION; FLUORESCENCE; GEL FILTRATION; HUMAN; HYDROPHOBICITY; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; ANILINO NAPHTHALENESULFONATES; BINDING SITES; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; CIRCULAR DICHROISM; CYSTATINS; DATABASES, FACTUAL; DIMERIZATION; ESCHERICHIA COLI; FLUORESCENT DYES; HUMANS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; POINT MUTATION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; TEMPERATURE; UREA; VARIATION (GENETICS);

EID: 0347363908     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.03270904     Document Type: Article

References (38)

1. Barrett, A.J. and Kirschke, H. 1981. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 80: 535-561.
2. Brzin, J., Kopitar, M., Turk, V., and Machleidt, W. 1983. Protein inhibitors of cysteine proteinases. I. Isolation and characterization of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe Seylers Z. Physiol. Chem. 364: 1475-1480.
3. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., and Dobson, C.M. 2002. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9: 137-143.
4. Di Giamo, R., Riccio, M., Santi, S., Galeotti, C., Ambrosetti, D.C., and Melli, M. 2002. New insights into the molecular basis of progressive myoclonus epilepsy: A multiprotein complex with cystatin B. Hum. Mol. Gen. 11: 2941-2950.
5. Dobson, C.M. 2001. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B 356: 133-145.
6. Goers, J., Permyakov, S.E., Permyakov, E.A., Uversky, V.N., and Fink, A.L. 2002. Conformational prerequisites for α-lactalbumin fibrillation. Biochemistry 41: 12546-12551.
7. Jackson, S.E., Moracci, M., elMasry, N., Johnson, C.M., and Fersht, A.R. 1993. Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2. Biochemistry 32: 11259-11269.
8. Janowski, R., Kozak, M., Jankowska, E., Gzonka, Z., Grubb, A., Abrahamson, M., and Jaskolski, M. 2001. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8: 316-320.
9. Jenko, S., Dolenc, I., Guncar, G., Doberšek, A., Podobnik, M., and Turk, D. 2003. Crystal structure of stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exo-peptidases. J. Mol. Biol. 326: 875-885.
10. Jerala, R. and Žerovnik, E. 1999. Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions. J. Mol. Biol. 291: 1079-1089.
11. Jerala, R., Trstenjak, M., Lenarčič, B. and Turk, V. 1988. Cloning a synthetic gene for human stefin B and its expression in E. coli. FEBS Lett. 239: 41-44.
12. Jerala, R., Kroon-Žitko, L., and Turk, V. 1994. Improved expression and evaluation of polyethyleneimine precipitation in isolation of recombinant cysteine proteinase inhibitor stefin B. Protein Expr. Purif. 5: 65-69.
13. Jones, S., Manning, J., Kad, N.M., and Radford, S.E. 2003. Amyloid-forming peptides from β(2)-microglobulin-Insights into the mechanism of fibril formation in vitro. J. Mol. Biol. 325: 249-257.
14. Kelly, J.W. 1996. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6: 11-17.
15. Kenig, M., Jerala, R., Kroon-Žitko, L., Turk, V., and Žerovnik, E. 2001. Major differences in stability and dimerization properties of two chimeric mutants of human stefins. Proteins 42: 512-522.
16. Lieuallen, K., Pennacchio, L.A., Park, M., Myers, R.M., and Lennon, G.G. 2001. Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum. Mol. Genet. 10: 1867-1871.
17. Manning, M.C. and Woody, R.W. 1989. Theoretical study of the contribution of aromatic side chains to the circular dichroism of basic bovine pancreatic trypsin inhibitor. Biochemistry 28: 8609-8613.
18. Martin, J.R., Craven, C.J., Jerala, R., Kroon-Žitko, L., Žerovnik, E., Turk, V., and Waltho, J.P. 1995. The three-dimensional solution structure of human stefin A. J. Mol. Biol. 246: 331-343.
19. McParland, V.J., Kad, N.M., Kalverda, A.P., Brown, A., Kirwin-Jones, P., Hunter, M.G., Sunde, M., and Radford, S.E. 2000. Partially unfolded states of β(2)-microglobulin and amyloid formation in vitro. Biochemistry 39: 8735-8746.
20. Pennacchio, L.A., Lehesjoki, A.E., Stone, N.E., Willour, V.L., Virtaneva, K., Miao, J., D'Amato, E., Raminez, L., Faham, M., Koskiniemi, M., et al. 1996. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271: 1731-1734.
21. Pennacchio, L.A., Bouley, D.M., Higgins, K.M., Scott, M.P., Noebels, J.L., and Myers, R.M. 1998. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet. 20: 251-258.
22. Rinne, R., Jarvinen, S.P., and Lehesjoki, A.E. 2002. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann. Med. 34: 380-385.
23. Sanger, F., Nicklen, S., and Coulson, A.R. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. 74: 5463-5467.
24. Santoro, M.M. and Bolen, D.W. 1988. Unfolding free energy changes determined by the linear extrapolation method. I. Unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants. Biochemistry 27: 8063-8068.
25. Staniforth, R.A., Giannini, S., Higgins, L.D., Conroy, M.J., Hounslow, A.M., Jerala, R., Craven, C.J., and Waltho, J.P. 2001. Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20: 4774-4781.
26. Stubbs, M.T., Laber, B., Bode, W., Huber, R., Jerala, R., Lenarčič, B., and Turk, V. 1990. The refined 2.4 Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: A novel type of proteinase inhibitor interaction. EMBO J. 9: 1939-1947.
27. Turk, V. and Bode, W. 1991. The cystatins: Protein inhibitors of cysteine proteinases. FEBS Lett. 285: 213-219.
28. Turk, V., Turk, B., and Turk, D. 2001. Lysosomal cysteine proteinases: Facts and opportunities. EMBO J. 20: 4629-4633.
29. Ventura, S., Lacroix, E., and Serrano, L. 2002. Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. J. Mol. Biol. 322: 1147-1158.
30. Žerovnik, E., Lohner, K., Jerala, R., Laggner, P., and Turk, V. 1992a. Calorimetric measurements of thermal denaturation of stefins A and B: comparison to predicted thermodynamics of stefin B unfolding. Eur. J. Biochem. 210: 217-221.
31. Žerovnik, E., Jerala, R., Kroon-Žitko, L., Pain, R.H., and Turk, V. 1992b. Intermediates in denaturation of a small globular protein, recombinant human stefin B. J. Biol. Chem. 267: 9041-9046.
32. Žerovnik, E., Jerala, R., Kroon-Žitko, L., Turk, V., and Lohner, K. 1997. Characterization of the equilibrium intermediates in acid denaturation of human stefin B. Eur. J. Biochem. 245: 364-372.
33. Žerovnik, E., Virden, R., Jerala, R., Turk, V., and Waltho, J.P. 1998a. On the mechanism of human stefin B folding: I. Comparison to homologous stefin A. Influence of pH and trifluoroethanol on the fast and slow folding phases. Proteins 32: 296-303.
34. Žerovnik, E., Jerala, R., Virden, R., Kroon-Žitko, L., Turk, V., and Waltho, J.P. 1998b. On the mechanism of human stefin B folding: II. Folding from GuHCl unfolded, TFE denatured, acid denatured, and acid intermediate states. Proteins 32: 304-313.
35. Žerovnik, E., Virden, R., Jerala, R., Kroon-Žitko, L., Turk, V., and Waltho, J.P. 1999. Differences in the effects of TFE on the folding pathways of human stefins A and B. Proteins 36: 205-216.
36. Žerovnik, E., Pompe-Novak, M., Škarabot, M., Ravnikar, M., Muševič, I., and Turk, V. 2002a. Human stefin B readily forms amyloid fibrils in vitro. Biochim. Biophys. Acta 1594: 1-5.
37. Žerovnik, E., Zavašnik-Bergant, V., Kopitar-Jerala, N., Pompe-Novak, M., Škarabot, M., Goldie, K., Ravnikar, M., Muševič, I., and Turk, V. 2002b. Amyloid fibril formation by human stefin B in vitro: Immunogold labelling and comparison to stefin A. Biol. Chem. 383: 859-863.
38. Žerovnik, E., Turk, V., and Waltho, J.P. 2002c. Amyloid fibril formation by human stefin B: Influence of the initial pH-induced intermediate state. Biochem. Soc. Trans. 30: 543-547.